Hepatitis B virus (HBV) infection is a major public health problem in the world. In Congo, studies on the prevalence of HBV infection are common but HDV infection is rare. Objective: Contribute to improve the management and prevention of HBV and HDV infections. Patients and Methods: This was a descriptive and cross-sectional study conducted from January to August 2016 in the health services of the various departments of Congo and at the national public health laboratory in Brazzaville. All patients with HBsAg surface antigen who were at least 18 years old and who consented to the study were included. The HBs antigen was first tested by a rapid test then confirmed by ELISA. All HBsAg positive patients were subsequently subjected to a second ELISA test for Delta antibody. The techniques of extraction and conventional and specific gene amplification were carried out on plasma for the identification of the genotypes of the two viruses. The data analysis was done with EpiInfo V7 software. The proportions were compared using the Chi-square test or the Fisher test at the significance level of 5%. Results: 1618 subjects were included, of whom 180 were positive for HBsAg, a frequency of 11.12%. The sex ratio (M/F) was 0.77%, the mean age was 40.2 ± 15.6 years with extremes ranging from 18 to 88 years. Of the 180 HBsAg positive, 22 were anti-VHD positive, a frequency of 12.22%. HBV DNA was amplified in 83.8% (151/180), HDV RNA in 63.6% (14/22). For HBV, three genotypes were identified: E (46.9%), A (43.7%) and D (9.4%), however for VHD three genotypes D1, D5, D8 were identified. Conclusion: Co-infection of hepatitis How to cite this paper:
Introduction
An estimated 350 million people are infected with the hepatitis B virus (HBV), 15 million with the hepatitis D virus (HDV) [1] . HDV is a satellite virus whose expression and multiplication requires the assistance of HBV and more precisely the presence of the surface antigen of this virus (HBsAg) [2] . About a quarter of the 65 million chronic carriers of HBV are suspected of being infected with HDV [3] . HDV infection can occur in two circumstances: simultaneous infection (co-infection) with both viruses or superinfection with HDV of a chronic carrier of HBV. Co-infection or superinfection may be responsible for fulminant forms or severe chronic course [4] . We distinguish the regions where the superinfection is endemic (southern Italy, Amazon Basin, certain areas of Africa and the Middle East); areas where superinfection is not endemic (North America, Western Europe) [5] [6] . Congo is considered a country of high endemicity of HBV. However, the high frequency of viral hepatitis B, the predominance of primary liver cancers in the same population, and the high rate of HBsAg carriers in presumed healthy subjects [5] [6] [7] suggest a high prevalence of HDV in the general population. However, the co-infection of hepatitis B virus and Delta is poorly documented in Congo. It is with this in mind that we have done this work in order to characterize the molecular profile of viral hepatitis B viruses and viral hepatitis D to help improve patient care.
Patients and Methods
This was a descriptive and cross-sectional study that ran from January 1 to August 30, 2016, for a period of 8 months. The study was conducted in the Republic of Congo in the Basic Hospitals and Integrated Health Centers (CSI) of the following departments: Likouala, Central basin, Sangha, Lekoumou, Niari, Pointe-Noire and Brazzaville. Serological and molecular analyzes were performed in Brazzaville at the National Public Health Laboratory (LNSP). The choice of health facilities that served as a survey frame was random. Included in our study were all patients, all at least 18 years old, outpatients present in the various localities mentioned above during the study period and who gave their verbal and/or written consent. We excluded patients who have been living for less than one year in the departments concerned, hospitalized patients and those who refused to give their consent.
The following epidemiological variables were studied: age and sex. Biological CGAGAACAAGA-3') in a TECHNE TC-312 thermocycler [9] . The PCR products were read on a 2% agarose gel in Tris-Borate-EDTA (TBE) buffer. The PCR products nested with HBV and HDV viruses were directly sequenced and the genotypes were identified using the BLAST algorithm by comparing the nucleotide sequences with the GenBank database (NCBI). Positive patients have been referred to specialized hospitals for treatment. The data analysis was done with EpiInfo V7 software. The proportions were compared using the Chi-square test or the Fisher test at the significance level of 5%.
Results
A total of 1618 patients benefited from samples for HBsAg research. The average age of our study population was 40.2 ± 15.6 years with extremes ranging from 18 to 88 years. The distribution of patients by age group is shown in Figure 1 Among the 9 subjects in whom the genotype of HDV could be identified, genotypes D1, D5, D8 were identically identified (1.11% for each genotype). Genotype details are reported in Table 1 .
Discussion
The high prevalence of HBsAg confirms Congo's place among countries with high HBV endemicity according to WHO [10] [11] . This rise can be explained by the absence of a policy to reduce the transmission of hepatitis viruses. Congo does not have a program to fight viral hepatitis. African studies report divergent results. Diara et al. in Mali reports a prevalence similar to ours (13.9%) [12] . In the Democratic Republic of the Congo, Namululi et al. (2012) report a lower prevalence [13] . Methodological approaches can explain the differences in our study, the seroprevalence of the anti-HDV antibody is 12.2%. This prevalence is low compared to those reported in the subregion by Foupouapouognigni et al. (2011) and Torimiro et al. (2014) in Cameroon which reports respectively 17.6%
and 22.6% [14] [15]. These high prevalences could be explained by selection bias in patient recruitment. Indeed, in the above-mentioned works, these were hospital and non-general populations as in our work. But our prevalence remains much higher than that reported by Sawadogo et al. (2016) in Bobo-Dioulasso, Burkina Faso, West Africa, which reports a prevalence of 3.4% of the hepatitis delta virus [16] . Gomaa et al. (2013) [17] . The difference would be related to study ( 
Conclusion
The results of this work emphasize that delta virus infection is a common infec- 
